Filing Details

Accession Number:
0001437749-22-027792
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-18 20:34:16
Reporting Period:
2022-11-16
Accepted Time:
2022-11-18 20:34:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659617 Moleculin Biotech Inc. MBRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
938419 V Walter Klemp C/O Moleculin Biotech, Inc.
5300 Memorial Dr., Suite 950
Houston TX 77007
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-16 85,213 $0.97 317,648 No 4 P Direct
Common Stock Acquisiton 2022-11-17 24,742 $1.02 342,390 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $0.935 to $1.02. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $0.995 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.